EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)

Show other versions (1)

Aim. To evaluate efficacy and safety of ramipril (Hartil, Egis) in treatment of patients with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical practice.Material and methods. 998 patients (424 men and 574 women; aged 57,4±0,4 y.o.) with HT;...

Full description

Bibliographic Details
Main Authors:	I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	arterial hypertension cardiovascular risk ramipril
Online Access:	https://www.rpcardio.online/jour/article/view/729

Similar Items

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Ramipril - angiotensin converting enzyme ingibitor with a wide spectrum of therapeutic action
by: Dmitriy Vladimirovich Preobrazhenskiy,, et al.
Published: (2009-03-01)

WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective
by: A Aurbach, et al.
Published: (2004-07-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
by: S. V. Nedogoda
Published: (2016-09-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
by: A. I. Chesnikova, et al.
Published: (2016-01-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
by: B J C Onwubere, et al.
Published: (2007-01-01)

EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
by: A. O. Konradi, et al.
Published: (2020-04-01)

EFFICACY OF INTERMITTENT NORMOBARIC HYPOXIC TRAINING IN THE TREATMENT OF ARTERIAL HYPERTENSION ASSESSED BY 24-HOUR BLOOD PRESSURE MONITORING
by: I A Velizhanina, et al.
Published: (2017-12-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
by: M. V. Leonova
Published: (2020-05-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
by: E. E. Averin, et al.
Published: (2019-01-01)

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
by: Omboni S, et al.
Published: (2015-10-01)

EFFICACY AND SAFETY OF FIXED RAMIPRIL + FELODIPINE COMBINATION IN TREATMENT OF ARTERIAL HYPERTENSION: A RETROSPECTIVE STUDY-FORECAST
by: Ivan Tasić, et al.
Published: (2013-03-01)

Ramipril induced pemphigoid vulgaris
by: Mirza MA, et al.
Published: (2018-09-01)

The Possibilities of Single-Pill Combinations of Antihypertensive Drugs in Cerebroprotection: Focus on the Combination of Amlodipine with Ramipril
by: A. I. Kochetkov, et al.
Published: (2020-07-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

COMPARISON OF EFFICACY AND SAFETY OF RAMIPRIL, MOLSIDOMINE AND THEIR COMBINATION IN PATIENTS WITH CHRONIC HEART FAILURE, WHICH COMPLICATED ISCHEMIC HEART DISEASE
by: I. I. Sinitsina, et al.
Published: (2016-01-01)

Comparative evaluation of the impact of candesartan and ramipril therapy on the levels of GDF 15 and NTproBNP, structural and functional performance of the heart in patients with coronary artery disease with asymptomatic diastolic dysfunction after myocar
by: V. D. Syvolap, et al.
Published: (2014-04-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
by: M.A. Dolinnayä, et al.
Published: (2017-03-01)

Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients: A Subgroup Analysis of RAMONA Trial
by: Gabor Simonyi
Published: (2016-01-01)

CHANGES IN THE PROOXIDATIVE-ANTIOXIDANT SYSTEM IN SHR SERIES RATS WITH TREATMENT OF HYPOTENSIVE MEDICINES (RAMIPRIL AND CANDESARTANE) IN COMBINATION WITH CORVITIN
by: Aliona Marushchak, et al.
Published: (2020-07-01)

The effects of single and combined application of ramipril and losartan on renal structure and function in hypertensive rats
by: Lin Yun, et al.
Published: (2018-10-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-10-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
by: Kateryna Typlynska, et al.
Published: (2023-04-01)

Combined Ramipril and Black Seed Oil Dosage Forms Using Bioactive Self-Nanoemulsifying Drug Delivery Systems (BIO-SNEDDSs)
by: Ahmad Abdul-Wahhab Shahba, et al.
Published: (2022-09-01)

Influence of angiotensin-converting enzyme inhibitor ramipril on indicators of tubular kidney lesion in patients with chronic glomerulonephritis
by: Dolinna Mariia O., et al.
Published: (2020-03-01)

Pengaruh Ramipril terhadap Gambaran Mikroskopis Sel Neuron Otak Tikus Wistar yang Mengalami Edema Otak
by: Muhammad Arief Ansyar, et al.
Published: (2022-05-01)

BEBERAPA TIPE LICHEN PLANUS ORAL YANG DIPICU OLEH RAMIPRIL DAN STRES EMOSIONAL (Laporan kasus)
by: Anandina Irmagita, et al.
Published: (2015-08-01)

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY
by: E. Malacco, et al.
Published: (2012-02-01)

Pengaruh Ramipril Terhadap Gambaran Histopatologis Otak Tikus Wistar yang Mengalami Edema Otak
by: Rizka Fitria Husni, et al.
Published: (2021-07-01)

Comparative evaluation of aliskiren, ramipril, and losartan on psychomotor performance in healthy volunteers: A preliminary report
by: Ekta Arora, et al.
Published: (2014-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
by: Katarzyna Regulska, et al.
Published: (2021-10-01)

Possibilities of rational combination antihypertensive therapy: Results of HEMERA international clinical trial
by: I E Chazova, et al.
Published: (2013-10-01)

Clinical efficacy of losartan and ramipril in male patients with hypertension depending on age, uricemia level, and hypertension type
by: V.P. Ivanov, et al.
Published: (2016-12-01)

Determination of ramipril in human plasma and its fragmentation by UPLC-Q-TOF-MS with positive electrospray ionization
by: Szpot Paweł, et al.
Published: (2015-06-01)